PUMA BIOTECHNOLOGY, INC. (PBYI) › RevenuePUMA BIOTECHNOLOGY, INC. (PBYI) — RevenueAnnual figures by fiscal year, from SEC filings.2017: $27.68M2018: $250.99M2019: $272.26M2020: $225.11M2021: $253.16M2022: $228.03M2023: $235.64M2024: $230.47M2025: $228.37M$228.37M2017Revenue (USD)2025Fiscal YearRevenueChange YoY2025$228.37M-0.9%2024$230.47M-2.2%2023$235.64M+3.3%2022$228.03M-9.9%2021$253.16M+12.5%2020$225.11M-17.3%2019$272.26M+8.5%2018$250.99M+806.6%2017$27.68M—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share